Repro India Limited
NSE: REPRO | Information Technology
Market Fundamentals
Stock Intelligence & News
Your Money Mindset Was Set by Age 7. Hereβs How to Reprogram It.
Your Money Mindset Was Set by Age 7. Hereβs How to Reprogram It.
Read Full Analysis βEli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in vivo CAR-T.
Read Full Analysis βRepro India Limited
REPRO INDIA LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis βAI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact β then instantly notifies you via Email & WhatsApp only for the stocks you track.
Get instant alerts when REPRO breaks news
Join investors who track Repro India Limited on Alerfo β free plan available.
Set Free Alert βFrequently Asked Questions
What is the current trend for REPRO?
REPRO is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Repro India Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding REPRO to your custom watchlist.
